Genflow Biosciences (LON:GENF) Reaches New 12-Month High – Still a Buy?

Shares of Genflow Biosciences plc (LON:GENF) reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as GBX 2.90 and last traded at GBX 2.87, with a volume of 2560150 shares trading hands. The stock had previously closed at GBX 2.80.

Genflow Biosciences Trading Down 5.2%

The stock has a market capitalization of £14.06 million, a P/E ratio of -5.23 and a beta of 2.11. The business has a fifty day simple moving average of GBX 2.06 and a 200 day simple moving average of GBX 1.98.

Genflow Biosciences (LON:GENF) last posted its earnings results on Thursday, April 30th. The company reported GBX (0.33) earnings per share for the quarter. Genflow Biosciences had a net margin of 840.76% and a return on equity of 377.33%.

About Genflow Biosciences

Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.